Details of the Drug Excipient
General Information of Drug Inactive Ingredient (DIG) (ID: E00607)
| DIG Name |
Lithol rubin BCA
|
||||
|---|---|---|---|---|---|
| Synonyms |
5281-04-9; D&C Red No. 7; Brilliant Carmine 6B; Lithol Rubin BCA; D&C Red 7; C.I. Pigment Red 57, calcium salt; UNII-ECW0LZ41X8; ECW0LZ41X8; C.I. Pigment Red 57, calcium salt (1:1); C.I. 15850:1; E180; Calcium 3-hydroxy-4-((4-methyl-2-sulphonatophenyl)azo)-2-naphthoate; Calcium 3-hydroxy-4-(4-methyl-2-sulphonatophenyl)azo-2-naphthoate; 2-Naphthalenecarboxylic acid, 3-hydroxy-4-((4-methyl-2-sulfophenyl)azo)-, calcium salt (1:1); 2-Naphthalenecarboxylic acid, 3-hydroxy-4-[(4-methyl-2-sulfophenyl)azo]-, calcium salt (1:1); Lithol rubin B ca; D & C Red no. 7; C.I. Pigment Red 57:1; CCRIS 4903; calcium 3-hydroxy-4-[(4-methyl-2-sulphonatophenyl)azo]-2-naphthoate; CI 15850:1 (Ca salt); 2-Naphthalenecarboxylic acid, 3-hydroxy-4-(2-(4-methyl-2-sulfophenyl)diazenyl)-, calcium salt (1:1); 2-Naphthalenecarboxylic acid, 3-hydroxy-4-[2-(4-methyl-2-sulfophenyl)diazenyl]-, calcium salt (1:1); EINECS 226-109-5; DSSTox_CID_7594; DSSTox_RID_78520; DSSTox_GSID_27594; SCHEMBL341670; SCHEMBL3184572; CHEMBL2028348; DTXSID7027594; DTXSID30967273; Tox21_202750; MFCD00059529; 2-Naphthalenecarboxylic acid, 3-hydroxy-4-((4-methyl-2-sulfophenyl)azo)-, calcium salt; 3-Hydroxy-4-((2-sulfo-p-tolyl)azo)-2-naphthalenecarboxylic acid, calcium salt (1:1); 3-Hydroxy-4-((4-methyl-2-sulfophenyl)azo)-2-naphthalenecarboxylic acid, calcium salt; NCGC00260298-01; 5281-09-4; CAS-5281-04-9; L0075; EC 226-109-5; W-109152; Q27095541; 3-Hydroxy-4-[(4-methyl-2-sulfophenyl)azo]-2-naphthoic acid calcium salt; Calcium 3-hydroxy-4-((4-methyl-2-sulfonatophenyl)diazenyl)-2-naphthoate; calcium 3-hydroxy-4-[(E)-(4-methyl-2-sulfonatophenyl)diazenyl]-2-naphthoate; Calcium 4-[2-(4-methyl-2-sulfonatophenyl)hydrazinylidene]-3-oxo-3,4-dihydronaphthalene-2-carboxylate
|
||||
| DIG Function |
Colorant
|
||||
| Formula |
C18H12CaN2O6S
|
||||
| Canonical SMILES |
CC1=CC(=C(C=C1)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)O)[O-])S(=O)(=O)[O-].[Ca+2]
|
||||
| InChI |
1S/C18H14N2O6S.Ca/c1-10-6-7-14(15(8-10)27(24,25)26)19-20-16-12-5-3-2-4-11(12)9-13(17(16)21)18(22)23;/h2-9,21H,1H3,(H,22,23)(H,24,25,26);/q;+2/p-2
|
||||
| InChIKey |
PZTQVMXMKVTIRC-UHFFFAOYSA-L
|
||||
| Physicochemical Properties | Molecular Weight | 424.4 | Topological Polar Surface Area | 151 | |
| XlogP | N.A. | Complexity | 663 | ||
| Heavy Atom Count | 28 | Rotatable Bond Count | 3 | ||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 8 | ||
Full List of Drug(s) Co-administrated with This DIG